Categories: Wire Stories

Global Self-injections Market Forecast Report to 2027: A $86 Billion Market by 2027, with CAGR of 12.79% – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Self-injections Market Intelligence Report – Global Forecast to 2027” report has been added to ResearchAndMarkets.com’s offering.

The Global Self-injections Market is projected to reach USD 86,009.00 million by 2027 from USD 41,757.64 million in 2021, at a CAGR 12.79% during the forecast period.

Key Findings:

  • The Americas Self-injections Market size was estimated at USD 14,480.50 million in 2021 and expected to reach USD 15,973.70 million in 2022, at a CAGR 12.26% to reach USD 28,987.16 million by 2027.
  • The Asia-Pacific Self-injections Market size was estimated at USD 11,116.51 million in 2021 and expected to reach USD 12,557.66 million in 2022, at a CAGR 13.14% to reach USD 23,321.48 million by 2027.
  • The Europe, Middle East & Africa Self-injections Market size was estimated at USD 16,160.62 million in 2021 and expected to reach USD 18,199.61 million in 2022, at a CAGR 13.03% to reach USD 33,700.35 million by 2027.

Market Segmentation & Coverage:

The years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

The report categorizes the self-injections to forecast the revenues and analyze the trends in each of the following sub-markets:

Type:

  • Auto-Injectors
  • Needle-free Injectors
  • Pen Injectors
  • Wearable Injectors

Usage:

  • Disposable
  • Reusable

Distribution Channel:

  • Hospital Pharmacies
  • Online Pharmacies
  • Private Clinics

Therapeutic Areas Application:

  • Autoimmune Diseases
    • AIDS
    • Allergies
    • Cancer
    • Irritable Bowel Disorders
    • Multiple Sclerosis
    • Psoriasis
  • Emergency Drugs
    • Anaphylactic Socks
    • Migraine
  • Hormone Replacement Therapies
    • Beta-Interferon
    • Erythropoietin
    • Follicle Stimulating Hormone
    • Heparin
    • Insulin
    • Parathyroid Hormone
    • Parkinson’s

Company Profiles:

  • AbbVie Inc.
  • Antares Pharma, Inc.
  • Baxter International, Inc.
  • Becton, Dickinson and Company
  • Credence MedSystems, Inc.
  • DALI Medical Devices
  • Eli Lilly and Company
  • Enable Injections, Inc.
  • Gerresheimer AG
  • Insulet Corporation
  • Owen Mumford Limited
  • PenJet Corporation
  • Pfizer Inc.
  • PharmaJet, Inc.
  • Recipharm AB
  • SCHOTT AG
  • SHL Group
  • Terumo Corporation
  • West Pharmaceutical Services, Inc.
  • Wilhelm Haselmeier GmbH & Co. KG
  • Ypsomed Group

Key Topics Covered:

1. Preface

1.1. Objectives of the Study

1.2. Market Segmentation & Coverage

1.3. Years Considered for the Study

1.4. Currency & Pricing

1.5. Language

1.6. Limitations

1.7. Assumptions

1.8. Stakeholders

2. Research Methodology

3. Market Overview

4. Americas Self-injections Market

4.1. Introduction

4.2. Argentina

4.3. Brazil

4.4. Canada

4.5. Mexico

4.6. United States

5. Asia-Pacific Self-injections Market

5.1. Introduction

5.2. Australia

5.3. China

5.4. India

5.5. Indonesia

5.6. Japan

5.7. Malaysia

5.8. Philippines

5.9. Singapore

5.10. South Korea

5.11. Taiwan

5.12. Thailand

6. Europe, Middle East & Africa Self-injections Market

6.1. Introduction

6.2. France

6.3. Germany

6.4. Italy

6.5. Netherlands

6.6. Qatar

6.7. Russia

6.8. Saudi Arabia

6.9. South Africa

6.10. Spain

6.11. United Arab Emirates

6.12. United Kingdom

7. Company Usability Profiles

  • AbbVie Inc.
  • Antares Pharma, Inc.
  • Baxter International, Inc.
  • Becton, Dickinson and Company
  • Credence MedSystems, Inc.
  • DALI Medical Devices
  • Eli Lilly and Company
  • Enable Injections, Inc.
  • Gerresheimer AG
  • Insulet Corporation
  • Owen Mumford Limited
  • PenJet Corporation
  • Pfizer Inc.
  • PharmaJet, Inc.
  • Recipharm AB
  • SCHOTT AG
  • SHL Group
  • Terumo Corporation
  • West Pharmaceutical Services, Inc.
  • Wilhelm Haselmeier GmbH & Co. KG
  • Ypsomed Group

For more information about this report visit https://www.researchandmarkets.com/r/g9af8y

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T. Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Alex

Recent Posts

BW LPG Limited – Q1 2024 Financial Report Release and Earnings Presentation on 30 May 2024

SINGAPORE--(BUSINESS WIRE)--BW LPG Limited (“BW LPG”, the “Company”, OSE ticker code: “BWLPG.OL”, NYSE ticker code:…

19 mins ago

XTransfer Joins the Middle East Delegation of Hong Kong SAR

Explores Local Development Opportunities HONG KONG SAR - Media OutReach Newswire - 16 May 2024…

1 hour ago

Redress Design Award 2024 Finalists Announced, Competing For Tommy Hilfiger Retail Project

10 top emerging talents to showcase on runway final of world’s leading sustainable fashion design…

2 hours ago

BW LPG – Result of Court Hearing Regarding the Redomiciling to Singapore

SINGAPORE--(BUSINESS WIRE)--Reference is made to the stock exchange announcement made by BW LPG Limited ("BW…

2 hours ago

Most of the world is living under eroding democratic accountability

The world's 12 most populous countries saw declines in a global index measuring democratic accountability.…

3 hours ago

Graphisoft Takes Center Stage as Title Sponsor at Singapore Archifest 2024, Showcasing Innovation and Leadership in Architecture

Singapore and regional Industry professionals can anticipate Graphisoft’s latest BIM product innovations, including BIMx on…

4 hours ago